secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2026-09-25T12:30:07+00:00
Accession:  0001477449-26-000046
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Teladoc Chief Legal Officer Adam Vandervoort resigns effective Nov 1, 2026; Jonathan Dorfman named successor
--------------------------------------------------------------------------------

- Adam C. Vandervoort, Chief Legal Officer and Secretary, informed Teladoc on September 24, 2026 he will resign effective November 1, 2026.
- Resignation was made 'with good reason' under his executive severance agreement, implying a constructive-termination claim.
- Jonathan Dorfman, currently SVP, Securities & Corporate Law, will assume the Chief Legal Officer and Secretary role.
- Vandervoort will provide transition advisory services until November 1, 2027 and will receive no compensation for them.
- Filing signed by Vandervoort as Chief Legal Officer on September 25, 2026; no other officer or director changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000046/0001477449-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000046/tdoc-20260924.htm
  HTML page:      https://secwatch.observer/filing/0001477449-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer